Kannan Subburaj
Department of Medicine, Division of Gastroenterology, School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-6145, USA.
Cell Biol Int. 2003;27(2):153-63. doi: 10.1016/s1065-6995(02)00296-2.
CD36 is a platelet surface receptor protein that plays a major role in platelet aggregation and accumulation that is mediated by parasitic attachment. The CD36 receptor is constitutively phosphorylated by E-kinase/PKA, resulting in increased affinity for collagen, but preventing spontaneous platelet aggregation. Dephosphorylation of CD36 by protein phosphatase 2A (PP2A) leads to increased affinity for thrombospondin at a different rate than that of collagen-mediated platelet aggregation. Depletion of the E-kinase/PKA substrate ATPby E-NTPase-mediated hydrolysis, in conjunction with inhibition of PP2A by okadaic acid, could prove to be a valuable tool in inhibiting CD36 activation, thus preventing platelet aggregation and thrombus formation.
CD36是一种血小板表面受体蛋白,在由寄生虫附着介导的血小板聚集和积累中起主要作用。CD36受体由E激酶/PKA组成性磷酸化,导致对胶原蛋白的亲和力增加,但可防止血小板自发聚集。蛋白磷酸酶2A(PP2A)使CD36去磷酸化,导致对血小板反应蛋白的亲和力以不同于胶原蛋白介导的血小板聚集的速率增加。通过E-NTPase介导的水解作用消耗E激酶/PKA底物ATP,并结合冈田酸对PP2A的抑制作用,可能成为抑制CD36活化从而防止血小板聚集和血栓形成的一种有价值的工具。